Hypertrophic Cardiomyopathy Recommendations 2011 (Recomendaciones 2011 para Cardiopatía Hipertrófica)

Nov 24 • Artículos • 1241 Views • No Comments on Hypertrophic Cardiomyopathy Recommendations 2011 (Recomendaciones 2011 para Cardiopatía Hipertrófica)

News Author: Steve Stiles

Hypertrophic cardiomyopathy (HCM) is a treatable disease compatible with
a normal lifespan, and it is the most common inherited cardiac disease with an
incidence of 1 in 500 worldwide. More than 1400 mutations account for
approximately 50% of identifiable patients with HCM. It remains the most common
cause of sudden cardiac death among young adults, and patients should not
participate in competitive or intense sports.

This
practice guideline from the American College of Cardiology Foundation (ACCF)
and the American Heart Association (AHA) is based on a comprehensive literature
review through January 2011. Ranking recommendations according to level of
evidence, the guideline addresses patients and providers based in North
America. The recommendations for pediatric and adolescent populations were
integrated into the document.

Extracted from Medscape Cardiology Education

 

descargar documento completo

Related Posts

« »